Tracking and Evaluation Core

Information

  • Research Project
  • 10281661
  • ApplicationId
    10281661
  • Core Project Number
    U54GM115458
  • Full Project Number
    2U54GM115458-06
  • Serial Number
    115458
  • FOA Number
    PAR-20-175
  • Sub Project Id
    7201
  • Project Start Date
    9/1/2016 - 8 years ago
  • Project End Date
    6/30/2026 - a year from now
  • Program Officer Name
  • Budget Start Date
    7/1/2021 - 3 years ago
  • Budget End Date
    6/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    06
  • Suffix
  • Award Notice Date
    9/1/2021 - 3 years ago

Tracking and Evaluation Core

Tracking & Evaluation Core Project Summary The Tracking and Evaluation (T&E) Core works closely with the Administrative, other Cores and Pilot Project Program to analyze the performance of the Great Plains (GP) IDeA-CTR in a collaborative evaluation model. The evaluation addresses 3 specific aims: Aim 1) Assess the effectiveness of the GP IDeA-CTR in creating the environment and culture to support innovative and collaborative clinical and translational research; Aim 2) Evaluate how GP IDeA-CTR programs, resources, and services affect scientific productivity and the movement of research across the translational spectrum, with a focus on short- and long- term goals, milestone attainment, budget effectiveness, and leveraging data for informed decisions, strategic planning, and continuous improvement; and Aim 3) Use T&E feedback across teams and the network to improve collaborative team science, in a model that provides stakeholders with actionable metrics to assess GP IDeA-CTR outcomes, impact, and benefits to the community and region. The evaluation process uses cutting-edge, validated approaches and 14 evaluation metrics that include several tools with established validity evidence. The collaborative approach will engage CTR leadership and governance, Cores, and other stakeholders in ensuring the usefulness of evaluation and feedback, while balancing the value of information to stakeholders against the burden of data collection. Evaluation is expected to have a positive effect on GP IDeA-CTR priorities, such as enhancing the environment for team science, moving translational research across the spectrum, and fostering team science competencies. This will enhance the ability of the GP IDeA- CTR to maximally benefit stakeholders and the region, identify factors associated with successful CTR outcomes, and add to the repository of methods and tools for evaluating change and improvement efforts in large, complex translational science systems.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    U54
  • Administering IC
    GM
  • Application Type
    2
  • Direct Cost Amount
    56766
  • Indirect Cost Amount
    30086
  • Total Cost
  • Sub Project Total Cost
    86852
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIGMS:86852\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF NEBRASKA MEDICAL CENTER
  • Organization Department
  • Organization DUNS
    168559177
  • Organization City
    OMAHA
  • Organization State
    NE
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    681987835
  • Organization District
    UNITED STATES